Open AccessSCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer
Author(s) -
Jiayan Lou,
Lingjia Wei,
He Wang
Publication year - 2022
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s351976
Subject(s) - ovarian cancer , medicine , immune system , nomogram , malignancy , carcinogenesis , oncology , dna methylation , biomarker , proportional hazards model , methylation , cancer , cancer research , gene expression , immunology , gene , biology , genetics
Ovarian cancer (OV) is a common malignancy affecting women globally; recognizing useful biomarkers has been one of the key priorities. Since SCNN1A was reported to be relevant to tumor progression in a variety of cancers, but rarely in ovarian cancer, we explored the roles of SCNN1A in OV.